Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement

TUCSON, Ariz., Jan. 19, 2024 /PRNewswire/ — Accelerate Diagnostics, Inc. (NASDAQ: AXDX) (the “Company”) today announced the pricing of an underwritten public offering consisting of 6,860,659 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, and for certain investors in lieu thereof, pre-funded units, each consisting of one pre-funded warrant to purchase one share of common stock and one warrant to purchase one share of common stock. The public offering price for each unit is $1.50 and the public offering price for each pre-funded unit is $1.49. The Company granted the underwriters a 30-day option to purchase up to an additional 1,029,098 shares of common stock and/or additional warrants to purchase up to 1,029,098 shares of common stock, in any combination thereof, at the public offering price, less underwriting discounts and commissions.

Read more at prnewswire.com